ExoCoBio, a global leader in exosome-based regenerative aesthetics, is pleased to announce that they have completed the acquisition of a majority ownership in BENEV, a global medical aesthetic company based in the U.S. Founded in 2000, BENEV is a pioneer in the medical aesthetics industry as the manufacturer and distributor of the world’s first growth factor-based skincare products. They have expanded their business to market and distribute other innovative medical aesthetics products, including an award-winning RF microneedling system, best-in-class PDO threads, and the Exosome Regenerative Complex developed by ExoCoBio in the U.S. and other countries.
Read the full article: ExoCoBio, A Leader in Exosome Technology, Completes the Acquisition of BENEV, a Global Medical Aesthetic Brand //
Source: https://www.prnewswire.com/news-releases/exocobio-a-leader-in-exosome-technology-completes-the-acquisition-of-benev-a-global-medical-aesthetic-brand-301875292.html